Exploring the potential of artificial intelligence in assessing the risk of gastric neoplastic lesions in patients with corpus atrophic gastritis

Gastric Cancer. 2026 Jan;29(1):159-168. doi: 10.1007/s10120-025-01679-7. Epub 2025 Oct 22.

Abstract

Background: Corpus atrophic gastritis (CAG) requires endoscopic-histological surveillance due to the risk of developing gastric neoplastic lesions (GNL). This study aimed to identify variables associated with GNL development at long-term follow-up using a Fisher score-based feature-ranking-approach coupled with a One-Class Support-Vector-Machine (SVM) model.

Methods: A dataset containing 30 clinical, endoscopic, and histological variables from consecutive CAG patients (2001-2023) adhering to a surveillance-program was considered. GNL presence at the longest available follow-up was recorded. Gastric biopsies and histological evaluations followed the updated-Sydney-system. A Fisher score-based feature ranking method and a One-Class SVM were employed to select key variables linked to GNL development, and then validated with synthetically generated data.

Results: Overall, 355 CAG patients were initially considered. Of these, 36 were excluded due to the presence of GNL at baseline gastroscopy, and 216 for missing data. Thus, a total of 103 patients were considered and grouped into: CAG patients with [22 patients (F 68.1%), median-age 68(35-83) years] and without GNL at follow-up [81 patients (F 72.8%) median-age 59(26-84) years]. After a median follow-up of 60(12-192) months, 13 epithelial GNL (gastric adenocarcinoma or high/low-grade dysplasia) and nine type-1 gastric-neuroendocrine-tumors (T1gNET) were recorded. Parietal-cell-antibodies and pepsinogen-I < 30 μg/l were associated with epithelial GNL and T1gNET. Antral inflammation and age > 60 were linked to epithelial GNL, while anti-thyroperoxidase-antibodies, smoking, and dyspeptic-symptoms were linked to T1gNET. Low-dose aspirin and H. pylori eradication therapy showed inverse associations with epithelial GNL and T1gNET, respectively.

Conclusions: This is the first study in which an AI-model simultaneously considers clinical, endoscopic, and histological features from a dataset of CAG patients, showing the potential to identify variables associated with GNL development.

Keywords: Artificial intelligence; Corpus atrophic gastritis; Gastric cancer; Gastric neoplastic lesion; One-class support vector machine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Artificial Intelligence*
  • Female
  • Follow-Up Studies
  • Gastritis, Atrophic* / complications
  • Gastritis, Atrophic* / pathology
  • Gastroscopy
  • Humans
  • Male
  • Middle Aged
  • Precancerous Conditions* / pathology
  • Risk Assessment / methods
  • Risk Factors
  • Stomach Neoplasms* / diagnosis
  • Stomach Neoplasms* / etiology
  • Stomach Neoplasms* / pathology